These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9458093)

  • 21. Chemoprevention of MNU-induced mammary tumors in the mature rat by 4-HPR and tamoxifen.
    Moon RC; Kelloff GJ; Detrisac CJ; Steele VE; Thomas CF; Sigman CC
    Anticancer Res; 1992; 12(4):1147-53. PubMed ID: 1386970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, suppresses the growth of carcinogen-induced mammary tumors.
    Cohen LA; Marks PA; Rifkind RA; Amin S; Desai D; Pittman B; Richon VM
    Anticancer Res; 2002; 22(3):1497-504. PubMed ID: 12168829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
    Gottardis MM; Jordan VC
    Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase I study of LGD1069 in adults with advanced cancer.
    Rizvi NA; Marshall JL; Dahut W; Ness E; Truglia JA; Loewen G; Gill GM; Ulm EH; Geiser R; Jaunakais D; Hawkins MJ
    Clin Cancer Res; 1999 Jul; 5(7):1658-64. PubMed ID: 10430065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
    Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
    Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoendocrine therapy in DMBA-induced rat mammary carcinoma.
    Morimoto T; Yamamoto H; Komaki K; Konishi N; Tanaka T; Yamakawa T; Mori T; Sasa M; Monden Y
    Tokushima J Exp Med; 1990 Dec; 37(3-4):59-68. PubMed ID: 2128782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
    Suh N; Wang Y; Williams CR; Risingsong R; Gilmer T; Willson TM; Sporn MB
    Cancer Res; 1999 Nov; 59(22):5671-3. PubMed ID: 10582681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats.
    Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC
    Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
    Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
    Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.
    Yen WC; Lamph WW
    Prostate; 2006 Feb; 66(3):305-16. PubMed ID: 16245282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ; Yao ZX
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
    Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
    Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
    Ben-Hur H; Kossoy G; Zusman I
    Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7,12-dimethylbenz(a)anthracene, respectively, in female Sprague-Dawley rats.
    Kubatka P; Bojková B; M ciková-Kalická K; Mníchová-Chamilová M; Adámeková E; Ahlers I; Ahlersová E; Cermáková M
    Folia Biol (Praha); 2001; 47(1):5-10. PubMed ID: 11232869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors.
    Matsumoto H; Koibuchi Y; Horiguchi J; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(1):145-51. PubMed ID: 11748473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [LGD1069: an antagonist to the X retinoid receptor].
    Lansiaux A; Formstecher P; Bailly C
    Bull Cancer; 2000 Mar; 87(3):235-8. PubMed ID: 10779810
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of tamoxifen-dependent rat mammary tumors.
    Zimniski SJ; Warren RC
    Cancer Res; 1993 Jul; 53(13):2937-9. PubMed ID: 8319198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
    Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
    Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.